================================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


                        DATE OF REPORT: JANUARY 28, 2004
                        (DATE OF EARLIEST EVENT REPORTED)



                            VASCULAR SOLUTIONS, INC.
             (Exact name of registrant as specified in its charter)


                         Commission File Number: 0-27605
                                  ------------


        MINNESOTA                                           41-1859679
(State of Incorporation)                       (IRS Employer Identification No.)

                               6464 SYCAMORE COURT
                          MINNEAPOLIS, MINNESOTA 55369
                    (Address of Principal Executive Offices)

                                 (763) 656-4300
              (Registrant's telephone number, including are code)




================================================================================



ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

(c) The following exhibit is being furnished herewith:

         99.1 Press Release, dated January 28, 2004, of Vascular Solutions, Inc.

ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

         The following information is being furnished under Item 12, Results of
Operations and Financial Condition. Such information, including the Exhibit
attached hereto, shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934:

         On January 28, 2004, Vascular Solutions, Inc. issued a press release to
         report the Company's results of operations and financial condition for
         the completed fiscal year ended December 31, 2003. The release is
         furnished as Exhibit 99.1 hereto and is incorporated herein by
         reference.


                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                            VASCULAR SOLUTIONS, INC.


Date: January 28, 2004                      By: /s/ James Hennen
                                                --------------------------------
                                                James Hennen
                                                CHIEF FINANCIAL OFFICER





                                  EXHIBIT INDEX


99.1     Press Release, dated January 28, 2004, of Vascular Solutions, Inc.